✦ LIBER ✦
PMC2 ESTIMATING COST-EFFECTIVENESS BASED ON RESULTS OF UNCONTROLLED CLINICAL TRIALS: OFATUMUMAB FOR THE TREATMENT OF FLUDARABINE- AND ALEMTUZUMAB-REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
✍ Scribed by AJ Batty; GJ Thompson; PA Maroudas; TE Delea
- Book ID
- 118614480
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 92 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.